Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer

Triple negative breast cancer (TNBC) account for 12% to 17% of all breast cancers. It is a heterogeneous group of tumors associated with aggressive clinical course. Insulin-like growth factor II mRNA binding protein 3 (IMP3) belongs to a family of insulin-like growth factor type II (IGF2), which pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Sjekloča, Nikoleta, Tomić, Snjezana, Mrklić, Ivana, Vukmirović, Filip, Vučković, Ljiljana, Lovasić, Ingrid Belas, Maras-Šimunić, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035046/
https://www.ncbi.nlm.nih.gov/pubmed/32049813
http://dx.doi.org/10.1097/MD.0000000000019091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035046/
https://www.ncbi.nlm.nih.gov/pubmed/32049813
http://dx.doi.org/10.1097/MD.0000000000019091

Ejemplares similares